Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma
Open Access
- 6 April 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 13 (11) , 1193-1204
Abstract
Glaucoma is a progressive blinding disease characterized by gradual loss of vision due to optic neuropathy and retinal ganglion cell death. Increased intraocular pressure is a common feature of glaucoma that is thought to arise from an increased resistance to outflow of aqueous humor through the trabecular meshwork. Mutations of the myocilin gene are one cause of autosomal dominant juvenile- and adult-onset primary open angle glaucoma, but the mechanism by which mutant myocilins cause disease is poorly understood. We have found that disease-causing myocilin mutants are misfolded, are highly aggregation-prone and accumulate in large aggregates in the endoplasmic reticulum (ER) of human embryonic kidney cells and differentiated primary human trabecular meshwork (HTM) cells. In HTM cells, Pro370Leu mutant myocilin is not secreted under normal culture conditions and prolonged expression results in abnormal cell morphology and cell killing. Culturing HTM cells at 30°C, a condition known to facilitate protein folding, promotes secretion of mutant myocilin, normalizes cell morphology and reverses cell lethality. Our results indicate that myocilin-associated glaucoma is an ER storage disease and suggest a progression of events in which chronic expression of misfolded, non-secreted myocilin leads to HTM cell death, trabecular meshwork dysfunction and, ultimately, a dominant glaucoma phenotype. The beneficial effects of facilitating folding and secretion of mutant myocilin suggest a new type of treatment for this form of glaucoma.Keywords
This publication has 50 references indexed in Scilit:
- Amassin, an olfactomedin protein, mediates the massive intercellular adhesion of sea urchin coelomocytesJournal of Cell Biology, 2003
- Myocilin and glaucoma: facts and ideasProgress in Retinal and Eye Research, 2002
- Inefficient Processing of an Olfactomedin-Deficient Myocilin Mutant: Potential Physiological Relevance to GlaucomaBiochemical and Biophysical Research Communications, 2001
- Ultrastructural Localization of Myocilin in Human Trabecular Meshwork Cells and TissuesJournal of Histochemistry & Cytochemistry, 2000
- Analysis of Myocilin Mutations in 1703 Glaucoma Patients From Five Different PopulationsHuman Molecular Genetics, 1999
- Gene Structure and Properties of TIGR, an Olfactomedin-related Glycoprotein Cloned from Glucocorticoid-induced Trabecular Meshwork CellsJournal of Biological Chemistry, 1998
- Recurrent Mutations in a Single Exon Encoding the Evolutionarily Conserved Olfactomedin-Homology Domain of TIGR in Familial Open-Angle GlaucomaHuman Molecular Genetics, 1997
- A Novel Myosin-like Protein (Myocilin) Expressed in the Connecting Cilium of the Photoreceptor: Molecular Cloning, Tissue Expression, and Chromosomal MappingGenomics, 1997
- Identification of a Gene That Causes Primary Open Angle GlaucomaScience, 1997
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996